Vaccine Scheduler
Sweden: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Birth | Weeks | Months | Years | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 6 | 7 | 3 | 5 | 6 | 12 | 18 | 2 | 5 | 6-8 | 10-12 | 13 | 14-16 | 17 | 18 | 26 | 45 | 60 | 64 | 65 | 74 | ≥ 75 | |||||
| RSV | RSV1 | RSV1 | |||||||||||||||||||||||||
| Coronavirus disease (COVID-19) | COVID-192 | COVID-192 | |||||||||||||||||||||||||
| tuberculosis | BCG3 | BCG3 | BCG3 | ||||||||||||||||||||||||
| rotavirus infection | ROTA | ROTA | ROTA4 | ||||||||||||||||||||||||
| diphtheria | D | D | D | D | d5 | d6 | |||||||||||||||||||||
| tetanus | TT | TT | TT | TT | TT5 | TT6 | |||||||||||||||||||||
| pertussis | acP | acP | acP | acP | acp5 | acp7 | |||||||||||||||||||||
| poliomyelitis | IPV | IPV | IPV | IPV | |||||||||||||||||||||||
| Haemophilus influenzae type b infection | Hib | Hib | Hib | ||||||||||||||||||||||||
| hepatitis B | HepB8 | HepB9 | HepB | HepB | HepB | HepB10 | |||||||||||||||||||||
| pneumococcal disease | PCV15 | PCV15 | PCV15 | PCV20 or PCV2111 | PCV20 or PCV2112 | ||||||||||||||||||||||
| measles | MEAS | MEAS13 | |||||||||||||||||||||||||
| mumps | MUMPS | MUMPS13 | |||||||||||||||||||||||||
| rubella | RUBE | RUBE13 | |||||||||||||||||||||||||
| human papillomavirus infection | HPV9 (F/M)14 | HPV9 (F/M)15 | HPV9 (F/M)16 | ||||||||||||||||||||||||
| influenza | IIV3 | IIV4 | |||||||||||||||||||||||||
Version:
Footnotes:
- Vaccination is recommended for all people aged 75 and over. Vaccination is recommended for people aged 60 and over with certain diseases, diagnoses or conditions. More information https://www.folkhalsomyndigheten.se/vara-amnesomraden/vaccinationer/vaccinationer-a-o/vaccination-mot-rs-virus/
- COVID-19 vaccination is recommended for individuals 18 years and above with immunosuppression, those 50 years of above belonging to certain risk groups, those 65 years and above with assistance in daily living, and everyone 75 years and above. For more information: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendationer-om-vaccination-mot-covid-19/
- As of May 2025, vaccination against tuberculosis is included in the Swedish national vaccination program for certain children, and thus funded by the state. BCG vaccination should be given at 6 weeks of age, or thereafter (up to 6 years of age) to children who are at increased risk of being infected with TB, because of having a household contact with origin from a country with increased or high TB incidence. For more information: https://www.folkhalsomyndigheten.se/vara-amnesomraden/vaccinationer/nationella-vaccinationsprogram/vaccinationsprogram-for-riskgrupper/vaccinationsprogram-for-riskgrupper-mot-tuberkulos/ BCG-vaccination is recommended (and usually financed by the region) for children up to 18 years of age with current TB in a close relative or household contact and those planning a longer stay (more than three months) in a country or area with high TB prevalence, if the child comes into close contact with the local population. For more information: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendationer-for-preventiva-insatser-mot-tuberkulos-halsokontroll-smittsparning-och-vaccination/ .
- 3rd dose only indicated when a pentavalent rotavirus vaccine is used.
- Given to 8-9 grade students.
- For adults above 18 years, dT booster doses are recommended every 20 years (not funded by the National Health system).
- Vaccination during every pregnancy is recommended after 16 weeks of pregnancy. More information: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendation-om-vaccination-mot-kikhosta-for-gravida/
- Babies born to a mother infected with hepatitis B will be offered a dose at birth.
- Babies born to a mother infected with hepatitis B are recommended a dose at birth and at 1 month of age, before continuing with the standard recommended schedule (with doses at 3, 5 and 12 months of age). More information: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendationer-om-vaccination-mot-hepatit-b-/?pub=56936
- Vaccination against hepatitis B is recommended for children up to 18 years belonging to certain risk groups. For more information, please visit: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendationer-om-vaccination-mot-hepatit-b-/
- Persons belonging to risk groups aged 2 years and above are recommended vaccination with a conjugate vaccine including at least 20 serotypes. Some risk groups should also be offered PPV23 in addition to PCV20 or PCV21. All adults are recommended vaccination with a conjugate vaccine including at least 20 serotypes at age 75 years. More information: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendationer-om-pneumokockvaccination-/
- Persons belonging to risk groups aged 2 years and above are recommended vaccination with a conjugate vaccine including at least 20 serotypes and/or PPS23. All adults are recommended vaccination with a conjugate vaccine including at least 20 serotypes at age 75 years. More information: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendationer-om-pneumokockvaccination-/
- Given to students in first or second grade
- Gender-neutral (boys and girls) school-based programme. 9-valent vaccine offered in fifth grade.
- Children 13-17 years are offered catch-up vaccinations (two doses) free of charge through school health care.
- Vaccination with two doses recommended up to 26 years of age. Funding, eligibility and implementation varies by region. For more information: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendationer-om-vaccination-mot-humant-papillomvirus-hpv/
More information available at:
https://www.folkhalsomyndigheten.se/vara-amnesomraden/vaccinationer/
______________________________________________________________________________________
HISTORICAL CHANGES TO THE SWEDISH NATIONAL IMMUNISATION PROGRAMME
- https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/communicable-disease-control/vaccinations/previous-swedish-vaccination-programmes/ (English)
- https://www.folkhalsomyndigheten.se/vara-amnesomraden/vaccinationer/nationella-vaccinationsprogram/tidigare-vaccinationsprogram/ (Swedish)
______________________________________________________________________________________
OTHER RELEVANT RESOURCES
PROCEDURE FOR CATCH-UP VACCINATIONS
https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/communicable-disease-control/vaccinations/catch-up-vaccinations/
CHANGES IN THE NATIONAL VACCINATION PROGRAMME
https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/communicable-disease-control/vaccinations/changing-national-vaccination-programmes/
______________________________________________________________________________________
Date of last update: 18 March 2026.